Long-term release and improved intracellular penetration of oligonucleotide-polyethylenimine complexes entrapped in biodegradable microspheres

Biomacromolecules

Volumn 4, Issue 3, 2003, Pages 529-536

  De Rosa, Giuseppe ^a,b   Quaglia, Fabiana ^b   Bochot, Amélie ^a   Ungaro, Francesca ^b   Fattal, Elias ^a  

^a UNIV PARIS SUD   (France)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADATION; EVAPORATION; SODIUM CHLORIDE;

MOLAR RATIO;

POLYETHERS;

MICROSPHERE; NITROGEN; OLIGONUCLEOTIDE; PHOSPHATE; POLYETHYLENEIMINE DERIVATIVE; POLYGLACTIN; SODIUM CHLORIDE; SOLVENT; WATER;

AQUEOUS SOLUTION; ARTICLE; BIODEGRADABILITY; CELL NUCLEUS; CELL PERMEABILIZATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG PENETRATION; EMULSION; ENCAPSULATION; ENZYME DEGRADATION; EVAPORATION; FETAL CALF SERUM; HELA CELL; HUMAN; HUMAN CELL; OSMOSIS; POROSITY; PRIORITY JOURNAL; SLOW RELEASE FORMULATION; SUSTAINED RELEASE FORMULATION; WATER TRANSPORT;

EID: 0037503753     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm025684c     Document Type: Article

References (28)

1. Myers, K. J.; Dean, N. M. Sensible use of antisense: how to use oligonucleotides as research tools. Trends Pharmacol. Sci. 2000, 21, 19-23.
2. Lebedeva, I.; Stein, C. A. Antisense oligonucleotides: promise and reality. Annu. Rev. Pharmacol. Toxicol. 2001, 41, 403-419.
3. Wallace, R. W. Does antisense make sense? Drug Discovery Today 1999, 4, 4-5.
4. Akhtar, S.; Kole, R.; Juliano, R. L. Stability of antisense DNA oligodeoxynucleotide analogues in cellular extracts and sera. Life Sci. 1991, 49, 1793-1801.
5. Agrawal, S.; Temsamani, J.; Tang, J. Y. Pharmacokinetics, Biodistribution, and Stability of Oligodeoxynucleotide Phosphorothioates in Mice. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 7595-7599.
6. Levin, A. A. A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides. Biochim. Biophys. Acta 1999, 1489, 69-84.
7. Agrawal, S. Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides. Biochim. Biophys. Acta 1999, 1489, 53-68.
8. Lewis, K. J.; Irwin, W. J.; Akhtar, S. Biodegradable poly(L-lactic acid) matrixes for the sustained delivery of antisense oligonucleotides. J. Controlled Release 1995, 37, 173-183.
9. Lewis, K. J.; Irwin, W. J.; Akhtar, S. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro. J. Drug Targeting 1998 5, 291-302.
10. Boussif, O.; Lezoualch'h, F.; Zanta, M. A.; Margny, M. D.; Scherman, D.; Demeneix, B.; Behr, J. P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 7297-7301.
11. Haensler, J., Jr.; Szoka, F. C. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjugate Chem. 1993, 4, 372-379.
12. Behr, J. P.; Demeneix, B.; Loeffler, J. P.; Perez-Mutul, J. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc. Natl. Acad. Sci. U.S.A. 1989, 89, 6982-6986.
13. Fattal, E.; Dubernet, C.; Couvreur, P. Liposome-based formulations for the delivery of oligonucleotides, S.T.P. Pharma Sci. 2001, 11, 31-44.
14. Remy, J.-S.; Abdallah, B.; Zanta, M. A.; Boussif, O.; Behr, J. P.; Demeneix, B. Gene transfer with lipospermines and polyethylenimines. Adv. Drug Delivery Rev. 1998, 30, 85-95.
15. Abdallah, B.; Hassan, A.; Benoist, C.; Goula, D.; Behr, J. P.; Demeneix, B. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine. Hum. Gene Ther. 1996, 7, 1947-1954.
16. Lemkine, G. F.; Goula, D.; Becker, N.; Paleari, L.; Levi, G.; Demeneix, B.; Optimisation of polyethylenimine-based gene delivery to mouse brain. J. Drug Targeting 1999, 7, 305-312.
17. Boussif, O.; Zanta, M. A.; Behr, J. P. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther. 1996, 3, 1074-1080.
18. De Rosa, G.; Quaglia, F.; La Rotonda, M. I.; Appel, M.; Alphandary, H.; Fattal, E. Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes. J. Pharm. Sci. 2002, 91, 790-799.
19. Rojas, J.; Pinto-Alphandary, H.; Leo, E.; Pecquet, S.; Couvreur, P.; Gulik, A.; Fattal, E. A polysorbate-based nonionic surfactant can modulate loading and release of beta-lactoglobulin entrapped in multiphase poly(DL-lactide-co-glycolide) microspheres. Pharm. Res. 1999, 16, 255-260.
20. Ungaro, F.; De Rosa, G.; Miro, A.; Quaglia, F.; Spectrophotometric determination of polyethylenimine in the presence of an oligonucleotide for the characterization of controlled release formulations. J. Pharm. Biomed. Anal., in press.
21. Aynie, I.; Vauthier, C.; Foulquier, M.; Malvy, C.; Fattal, E.; Couvreur, P. Development of a quantitative polyacrylamide gel electrophoresis analysis using a multichannel radioactivity counter for the evaluation of oligonucleotide-bound drug carrier. Anal. Biochem. 1996, 240, 202-209.
22. Couvreur, P.; Blanco-Prieto, M. J.; Puisieux, F.; Roques, B.; Fattal, E.; Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides. Adv. Drug Delivery Rev. 1997, 28, 85-96.
23. Pistel, K. F.; Kissel, T. Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique. J. Microencapsulation 2000, 17, 467-483.
24. Freytag, T.; Dashevsky, A.; Tillman, L.; Hardee, G. E.; Bodmeier, R. Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres. J. Controlled Release 2000, 69, 197-207.
25. Florence, T.; Whitehill, D. Stabilization of water/oil/water multiple emulsions by polymerization of the aqueous phases. J. Pharm. Pharmacol. 1982, 34, 687-691.
26. Lebedeva, I.; Benimetskaya, L.; Stein, C. A.; Vilenchik, M. Cellular delivery of antisense oligonucleotides. Eur. J. Pharm. Biopharm. 2000, 50, 101-119.
27. Juliano, R. L.; Alamari, S.; Yoo, H.; Kole, R.; Cho, M. Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides. Pharm. Res. 1999, 16, 494-502.
28. Leonetti, J. P.; Mechti, N.; Degolos, G.; Gagnor, C.; Lebleu, B. Intracellular-distribution of microinjected antisense oligonucleotides. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 2702-2706.